Zidovudine

ARV U.S. Brand Name

Retrovir

ARV Abbreviation(s)

AZT, ZDV

U.S. FDA Label

Zidovudine Drug Labeling (Package Inserts)

ARV Class

Nucleoside reverse transcriptase inhibitors

First U.S. Approval

March 19, 1987

U.S. Manufacturer

ViiV Healthcare

Formulations

Strength	Formulation	Image	Description	Boosted
300 mg	Tablet	X	white tablet with 300 imprint	No
100 mg	Capsules	X	white capsule with image of horse, Wellcome,100 Y9C imprint	No
10 mg/mL	Syrup	X	White bottle with Zidovudine Retrovir Syrup 10 mg/mL imprint	No

Generic Available?

Yes

FDCs

Abacavir / Lamivudine / Zidovudine

Assistance Programs

Displaying 1 - 15 of 15

	Interaction Color Code	Clinical Bottom Line	Clinical Effects	Drug 1 effect	Drug 2 dose	Drug 2 effect	Management
Emtricitabine AZT, ZDV 683	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 682	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 681	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 680	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 679	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 678	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 677	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 676	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 675	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Emtricitabine AZT, ZDV 674	Green: Administer standard doses	Administer standard doses		No significant change	300 mg once daily x 7 days	Cmax increased 17%, AUC increased 13%
Abacavir AZT, ZDV 671	Green: Administer standard doses	Administer standard doses		Inconsistent effect across all dosing regimens; No effect on AUC with clinical abacavir dose of 300mg BID	200 mg TID, 300 mg BID	No significant change
Abacavir AZT, ZDV 670	Green: Administer standard doses	Administer standard doses		No significant change	300 mg x 1 dose	Zidovudine Cmax decreased 20%; AUC no significant change
Nevirapine AZT, ZDV 602	Green: Administer standard doses	Administer standard doses		No significant change	100-200 mg TID
Efavirenz AZT, ZDV 429	Green: Administer standard doses	Administer standard doses		No significant change	300 mg Q12h x 14 days
Zidovudine

Subscribe to Zidovudine